To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Acute Post-op Clinical Benefit with Transdermal Buprenorphine Patch vs Oral Celecoxib in TKA Patient

Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
November 2020

Acute Post-op Clinical Benefit with Transdermal Buprenorphine Patch vs Oral Celecoxib in TKA Patient

Vol: 9| Issue: 11| Number:3| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Transdermal buprenorphine patch versus oral celecoxib for pain management after total knee arthroplasty: An open- label, randomized controlled trial.

Orthop Traumatol Surg Res. 2020 Sep;106(5):915-919.

Contributing Authors:
X Xu L Xie H Liu Y Hu

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

One hundred and sixty patients with knee osteoarthritis (OA) scheduled for a total knee arthroplasty were randomized to receive a transdermal buprenorphine patch or oral celecoxib for the relief of pain post-operation. Outcomes of interest included pain at rest and during activity on a Visual Analog Scale (VAS), range of motion, Lysholm Knee Scores, and the incidence of adverse events. Outcomes we...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue